FDA Panel Votes No On BD's Balloon For Below The Knee
Shifting trial design and missing data, plus little evidence of benefit, worked against the paclitaxel-coated balloon, panelists and US FDA speakers said.
You may also be interested in...
If approved, the device will be the first drug-coated balloon indicated specifically for use in arteries below the knee.
Can a false-claims suit be filed if doctors have different opinions about whether a treatment was necessary? The Supreme Court won’t say.
The proposed class action suit alleges that W.B. Mason took advantage of the pandemic by overcharging for the phony respirators.